OCS - Oculis Holding AG

QQQ $ 622.80 $ 0.00 (0 %)

DIA $ 470.47 $ 0.00 (0 %)

SPY $ 675.90 $ 0.00 (0 %)

TLT $ 89.78 $ 0.00 (0 %)

GLD $ 365.75 $ 0.00 (0 %)

Previous Close

$ 19.48

Open

$ 19.28

Bid

$ 18.80 x 1

Ask

$ 20.37 x 100

Day's Range

-- - --

52 Week Range

$ 14.00 - $ 23.08

Volume

198,677

Average Volume

Market Cap

319.44M

Beta (5Y Monthly)

$ 0.54

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Oculis Raises $110M Through Oversubscribed...
10/30/2025 08:33:58

Oculis intends to use the net proceeds from the financing to advance and accelerate the development of its novel neuroprotectiv...

Oculis To Highlight Late-Stage Ophthalmic ...
10/14/2025 08:14:17

eli-lilly-to-rally-more-than-12-here-are-10-top-analyst-forecasts-for-wednesday

Eli Lilly To Rally More Than 12%? Here Are...
10/08/2025 14:04:25

Chardan Capital Maintains Buy on Oculis Ho...
10/08/2025 11:19:47

Chardan Capital analyst Daniil Gataulin maintains Oculis Holding (NASDAQ:OCS) with a Buy and raises the price target from $3...

HC Wainwright & Co. Maintains Buy on Oculi...
10/07/2025 10:49:24

HC Wainwright & Co. analyst Yi Chen maintains Oculis Holding (NASDAQ:OCS) with a Buy and raises the price target from $3...

Oculis Advances Privosegtor Into FDA-Backe...
10/06/2025 08:10:57

Oculis Holding AG (NASDAQ:OCS) ("Oculis"), a global biopharmaceutical company focused on innovations addressing neuro-o...

Oculis Reports Trial Results Showing Visio...
09/22/2025 08:32:52

Oculis Holding AG (NASDAQ:OCS) ("Oculis"), a global biopharmaceutical company focused on innovations for ophthalmic and...

Reported Sunday, Oculis Announces Expanded...
09/02/2025 07:17:32

this-coreweave-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-wednesday

This CoreWeave Analyst Begins Coverage On ...
08/27/2025 15:23:54

Needham Initiates Coverage On Oculis Holdi...
08/27/2025 12:17:23

Needham analyst Serge Belanger initiates coverage on Oculis Holding (NASDAQ:OCS) with a Buy rating and announces Price Targe...

HC Wainwright & Co. Maintains Buy on Oculi...
08/22/2025 10:46:15

HC Wainwright & Co. analyst Yi Chen maintains Oculis Holding (NASDAQ:OCS) with a Buy and raises the price target from $3...

Oculis Holding Q2 EPS $(0.57) Misses $(0.5...
08/21/2025 20:15:33

Oculis Holding (NASDAQ:OCS) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.5...

Earnings Scheduled For August 21, 2025
08/21/2025 08:32:15

Uncovering Potential: Oculis Holding's Ear...
08/20/2025 15:02:35

Oculis Upsizes Loan Facility With BlackRoc...
08/01/2025 08:02:54

dave-to-rally-around-17-here-are-10-top-analyst-forecasts-for-friday

Dave To Rally Around 17%? Here Are 10 Top ...
05/09/2025 11:57:59

Chardan Capital Maintains Buy on Oculis Ho...
05/09/2025 10:43:40

Chardan Capital analyst Daniil Gataulin maintains Oculis Holding (NASDAQ:OCS) with a Buy and raises the price target from $2...

Oculis Holding Q1 EPS $(0.69) Misses $(0.4...
05/08/2025 21:13:47

Oculis Holding (NASDAQ:OCS) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.4...

intuit-to-rally-around-19-here-are-10-top-analyst-forecasts-for-thursday

Intuit To Rally Around 19%? Here Are 10 To...
04/17/2025 12:49:11

Chardan Capital Maintains Buy on Oculis Ho...
04/17/2025 11:34:47

Chardan Capital analyst Daniil Gataulin maintains Oculis Holding (NASDAQ:OCS) with a Buy and maintains $28 price target.